FDA Adverse Event Malfunction Summary report: N

T:SLIM X2 INSULIN PUMP WITH BASAL-IQ TECHNOLOGY

MDR report key: 18112783 · Received November 10, 2023

Report

Report Number
3013756811-2023-155547
Event Type
Malfunction
Date Received
November 10, 2023
Date of Event
October 19, 2023
Report Date
November 10, 2023
Manufacturer
TANDEM DIABETES CARE
Product Code
OZO
UDI-DI
00853052007325
PMA / PMN Number
K201214
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. THE TANDEM PUMP USER GUIDE INSTRUCTS THE USER TO REMOVE ANY RESIDUAL AIR FROM THE CARTRIDGE. THE CARTRIDGE IS INDICATED AS A RESERVOIR FOR THE DELIVERY OF RAPID-ACTING INSULIN WITH THE T:SLIM PUMP. HUMALOG® AND NOVOLOG® HAVE BEEN TESTED BY TANDEM DIABETES CARE, INC. AND FOUND TO BE SAFE FOR USE IN THE T:SLIM PUMP. HUMALOG® WAS TESTED FOR UP TO 48 HOURS AS LABELED, NOVOLOG® WAS TESTED FOR UP TO 72 HOURS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE INSULIN GAUGE WAS INACCURATE. REPORTEDLY, THE CUSTOMER DID NOT PERFORM THE AIR REMOVAL STEP AND USED THE CARTRIDGE BEYOND LABELING. CUSTOMER CONTINUED TO USE THE EXISTING CARTRIDGE THERE WAS NO ADVERSE IMPACT TO CUSTOMER¿S BLOOD GLUCOSE LEVEL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1832521 T:SLIM X2 INSULIN PUMP WITH BASAL-IQ TECHNOLOGY AUTOMATED INSULIN DOSING, THRESHOLD SUSPEND OZO TANDEM DIABETES CARE 1000354 00853052007325

Patients

Seq Age Sex Outcome Treatment
1 56 YR Female